Ashfa Anwar: While The World Is Editing Genes, Sri Lanka Is Still Thawing Plasma for Hemophilia
Ashfa Anwar, Biomedical Researcher from International College of Business and Technology, shared on LinkedIn:
”While the world is editing genes, Sri Lanka is still thawing plasma.
Let that sink in for a second.
I recently did a deep dive into Hemophilia A management for a literature review and what I found was honestly shocking.
Not because of how far science has come.
But because of how unevenly that progress is distributed.
Here’s what the world looks like right now:
- From plasma-based treatments like FFP and cryprecipitate to factor replacement, recombinant therapies, and emicizumab, the newest management startergy. Care has become progressively safer, more targeted, and more effective
- Gene Therapy – now at the frontier. Using vectors to deliver a functional gene directly into hepatocytes, enabling endogenous Factor VIII production.
And Sri Lanka?
Largely still at plasma based treatments and factor replacement
Recombinant therapy and emicizumab remain limited, with emicizumab mainly reserved for severe cases or patients with inhibitors
Gene therapy is not even part of the conversation here.
This is not criticism. It is a reality check.
Because the gap here is not scientific. It is systemic.
We are not waiting for breakthroughs. They already exist.
We are waiting for access, policy, and prioritisation to catch up.
So the real question is not ‘what is the future of haemophilia care?’
It is this:
Who gets to live in that future, and who gets left behind?”
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership